Is Illumina (ILMN) Quietly Solidifying an End‑to‑End Oncology Moat With Deeper DRAGEN Integration?

FierceBiotechAlnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer

Endpoints NewsADC biotech Ona Therapeutics secures $86.6M in Series B raise

BioPharma DiveA Spanish biotech banks $87M to make differentiated ADCs

Lonza NewsLonza advances integrated DNA‑to‑IND programmes with acceleration, derisking and innovation - Manufacturing Chemist

IlluminaIs Illumina (ILMN) Quietly Solidifying an End‑to‑End Oncology Moat With Deeper DRAGEN Integration? - simplywall.st

Clinical OMICsCAR T-Cell Therapy Expands Access to Kidney Transplants

Endpoints NewsAlnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal

FierceBiotechLilly, Boehringer to slash at least $1B each from planned investments in Germany

Clinical OMICsGenetically Raised Pulse Pressure Predisposes to Dementia-Linked Death

Clinical OMICsEngineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes

FierceBiotechUnlocking Unstructured Data with AI for Optimized Protocol Development